It has been shown that reduced UCP2 expression is associated with mitochondrial dysfunction, ROS accumulation and increased apoptosis; therefore, UCP2 may be involved in the pathogenesis of neurodegenerative diseases, including stroke (Cenini et al., 2019). Here, UCP2 is linked to neurodegenerative disease.